CORVUS PHARMACEUTICALS INC (CRVS) Institutional Ownership Changes & 13F Activity
CORVUS PHARMACEUTICALS INC (CRVS). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Price T Rowe Associates Inc, Eversept Partners, Lp, Bank Of America Corp, Wellington Management Group Llp, and Perceptive Advisors Llc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Manufacturers Life Insurance Company, The | Sell | -18,872 | -18.5% | 82,907 | $1.24M | Q2 2026 | Sep 09, 2026 |
| Citadel Advisors Llc | Sell | -44,571 | -10.1% | 397,951 | $5.95M | Q2 2026 | Sep 02, 2026 |
| Optimize Financial Inc | Sell | -97 | -0.3% | 27,963 | $417.77K | Q2 2026 | Aug 27, 2026 |
| California State Teachers Retirement System | Buy | +67,422 | +1927.4% | 70,920 | $1.06M | Q2 2026 | Aug 24, 2026 |
| Price T Rowe Associates Inc | Buy | +871,826 | +29.9% | 3,789,126 | $56.61M | Q2 2026 | Aug 14, 2026 |
| Eversept Partners, Lp | Buy | +747,994 | — | 747,994 | $11.18M | Q2 2026 | Aug 14, 2026 |
| Bank Of America Corp | Buy | +520,794 | +219.7% | 757,798 | $11.32M | Q2 2026 | Aug 14, 2026 |
| Wellington Management Group Llp | Buy | +413,115 | +17.8% | 2,731,632 | $40.81M | Q2 2026 | Aug 14, 2026 |
| Perceptive Advisors Llc | Buy | +375,000 | +16.4% | 2,667,441 | $39.85M | Q2 2026 | Aug 14, 2026 |
| Braidwell Lp | Buy | +373,500 | +21.3% | 2,126,298 | $31.77M | Q2 2026 | Aug 14, 2026 |
| Trexquant Investment Lp | Buy | +296,347 | — | 296,347 | $4.43M | Q2 2026 | Aug 14, 2026 |
| Two Sigma Investments, Lp | Buy | +245,339 | +45.4% | 785,208 | $11.73M | Q2 2026 | Aug 14, 2026 |
| Hood River Capital Management Llc | Buy | +236,696 | +17.7% | 1,571,805 | $23.48M | Q2 2026 | Aug 14, 2026 |
| Catalio Capital Management, Lp | Buy | +188,955 | +21.2% | 1,080,888 | $16.15M | Q2 2026 | Aug 14, 2026 |
| Millennium Management Llc | Buy | +181,623 | +21.0% | 1,047,985 | $15.66M | Q2 2026 | Aug 14, 2026 |
| Susquehanna International Group, Llp | Buy | +152,005 | +393.4% | 190,641 | $2.85M | Q2 2026 | Aug 14, 2026 |
| D. E. Shaw & Co., Inc. | Buy | +133,177 | — | 133,177 | $1.99M | Q2 2026 | Aug 14, 2026 |
| Brevan Howard Capital Management Lp | Buy | +82,320 | +49.0% | 250,291 | $3.74M | Q2 2026 | Aug 14, 2026 |
| Squarepoint Ops Llc | Sell | -79,691 | -64.3% | 44,205 | $660.42K | Q2 2026 | Aug 14, 2026 |
| Barclays Plc | Buy | +71,973 | +29.5% | 315,749 | $4.72M | Q2 2026 | Aug 14, 2026 |
| Caption Management, Llc | Buy | +64,034 | — | 64,034 | $956.67K | Q2 2026 | Aug 14, 2026 |
| Diadema Partners Lp | Buy | +50,000 | +20.4% | 294,811 | $4.40M | Q2 2026 | Aug 14, 2026 |
| Group One Trading Llc | Buy | +48,292 | — | 48,292 | $721.48K | Q2 2026 | Aug 14, 2026 |
| Invesco Ltd. | Buy | +41,702 | — | 41,702 | $623.03K | Q2 2026 | Aug 14, 2026 |
| Wells Fargo & Company/Mn | Buy | +38,396 | +164.3% | 61,765 | $922.77K | Q2 2026 | Aug 14, 2026 |
| Engineers Gate Manager Lp | Buy | +36,019 | — | 36,019 | $538.12K | Q2 2026 | Aug 14, 2026 |
| Legal & General Group Plc | Buy | +36,019 | +634.4% | 41,697 | $622.95K | Q2 2026 | Aug 14, 2026 |
| Goldman Sachs Group Inc | Buy | +35,543 | +2.3% | 1,576,352 | $23.55M | Q2 2026 | Aug 14, 2026 |
| Avidity Partners Management Lp | Sell | -35,000 | -30.4% | 80,000 | $1.20M | Q2 2026 | Aug 14, 2026 |
| Rafferty Asset Management, Llc | Sell | -31,114 | -27.6% | 81,494 | $1.22M | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about CRVS activity
Which institutional owners are buying CRVS?
Institutional owners buying CRVS include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in CRVS activity?
"Buy" means an investor increased their reported position in CRVS compared to the prior reporting period. This reflects growing exposure to CORVUS PHARMACEUTICALS INC (CRVS) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in CRVS increasing?
Institutional interest in CRVS can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related CRVS Institutional Insights
- CRVS Overview
- CRVS 13F Institutional Holders
- CRVS Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- CRVS Insider Trading & SEC Form 4 Activity
- CRVS Articles
- Top Institutional Investor Stock Rankings